Maximize your thought leadership

Nutriband Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference

By Advos
Nutriband's subsidiary Active Intelligence will present its expanding wellness product line at the ECRM conference, aiming to secure retail partnerships with major pharmacy and healthcare organizations.

Found this article helpful?

Share it with your network and spread the knowledge!

Nutriband Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference

Nutriband Inc. (NASDAQ: NTRB) announced that its wholly owned subsidiary, Active Intelligence, will participate in the June 2026 ECRM conference. The company plans to showcase its expanding portfolio of wellness, recovery, and performance-focused consumer products to buyers from major retail, pharmacy, and healthcare organizations. Active Intelligence will feature its existing AI Tape line and introduce new products including AI Performance Tape, AI Energy Patches, and AI Sleep, as it seeks to expand retail partnerships and distribution opportunities.

The ECRM conference is a key event for retailers and suppliers to meet and negotiate deals. By attending, Active Intelligence aims to secure shelf space for its products in major retail chains. The new product introductions represent a strategic expansion beyond the company's core transdermal pharmaceutical focus, leveraging its expertise in transdermal delivery systems for consumer wellness applications.

Nutriband primarily engages in the development of transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating AVERSA™ abuse-deterrent technology. This technology can be integrated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. However, the consumer wellness line through Active Intelligence provides a non-pharmaceutical revenue stream and brand visibility.

The success of this push could impact Nutriband's financial performance and stock valuation, as investors monitor the company's ability to diversify revenue sources. For the broader industry, Active Intelligence's entry into the wellness patch market, which includes energy and sleep patches, highlights the growing consumer demand for non-invasive, transdermal delivery systems for lifestyle benefits. If successful, it could encourage other pharmaceutical companies to explore similar consumer health applications.

For more information, the full press release is available at https://ibn.fm/sZ1zJ. The latest news and updates regarding Nutriband are available in the company’s newsroom at https://ibn.fm/NTRB.

Advos

Advos

@advos